Monday, July 15, 2019

Differences in MS patients' cerebrospinal fluid may be key to drugs that halt progression

Effective therapies exist for managing relapsing/remitting MS, but treatment for progressive MS has proved more challenging. Now, a new article has identified potential mechanisms that may inform the development of therapies that effectively manage progressive MS.

from Top Health News -- ScienceDaily https://ift.tt/2M0mUH0
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Common pesticide linked to more than double the risk of Parkinson’s disease

Scientists at UCLA have linked long-term exposure to the pesticide chlorpyrifos with a sharply increased risk of Parkinson’s disease. People...